Histone deacetylases (HDAC) are a class of enzymes that remove acetyl groups from the ε-N-acetyl lysine amino acid on a histone. It is involved in a series of pathways within the living system including cell cycle, signal transduction, and cancer such as chronic myeloid leukemia. Histone acetylation plays an important role in the regulation of gene expression. Deacetylation restores the positive electric charge of the lysine amino acids, which increases the histone's affinity for the negatively charged phosphate backbone of DNA. HDACs are involved in the pathway by which the retinoblastoma protein (pRb) suppresses cell proliferation. HDAC inhibitors are being studied as a treatment for cancer.
We have developed a novel HDAC assay for the detection of HDAC activity using fluorogenic HDAC Green™ substrate. Our non-peptide HDAC Green™ substrate is much more sensitive than the peptide-based HDAC substrates such as Ac-RGK(Ac)-R110, Ac-RGK(Ac)-AMC and Ac-RGK(Ac)-AFC. HDAC Green™ substrate is also much more resistant to protease hydrolysis than the other commercial peptide-based HDAC substrates. The HDAC Green provides a quick, convenient, and sensitive method for measuring HDAC activity in solutions and cell lysates. It can be readily used for screening HDAC inhibitors with cell extracts or purified enzymes due to its large assay window. The long wavelength emission and higher extinction coefficient of the HDAC Green™ substrate minimizes background interference from compounds and cell components.
Amplite® AChE Assay Workflow
HDAC Green™ Substrate Spectra